POM

Pomdoctor Limited

$1.60

3.23%
SectorHealthcareIndustryPharmaceutical RetailersCountryChina

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.

Source: Yahoo Finance
Q-Score34/ 100
Market Cap$4.4M
P/E—
Dividend Yield0.00%
52-Week Range—
Next Earnings—
Analysts—
Beta2.65
AI summary

Price & performance

1M+49.5%
3M+98.6%
YTD-76.3%
1Y-98.7%
52-week range—
Beta2.65
Full chart and returns against a benchmark

Q-Score

34/ 100

Quality against peers; 50 is the peer median.

Growth—
Risk6
Performance69
Valuation34
Profitability45
Leverage10
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$57.2M+21.8%
Net income-$18.7M
Net margin-32.7%-21.8 pts
Historical fundamentals

Red flags in filings

3active red flags
Going-concern doubtMay 14, 2026
Material weakness in controlsMay 14, 2026
Late filing noticeApr 30, 2026
Filings, findings and the timeline

Revenue exposure

All Other Segments100%
Largest customer46%
Regions, segments, customers and suppliers

Valuation

POMIndustryP/E——P/S0.080.35EV/EBITDA——P/B—2.19PEG——
Dividend yield0.00%
Every valuation metric